Trinity Surgical Consultants, Methodist Richardson Medical Center
Richardson, Texas, 75082, United States
Location status: Recruiting
Recruiting
NCT Number: NCT04055571
Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases
This study will be a retrospective chart review of patients who have been diagnosed with the benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, Texas(TX). The investigators plan to conduct an analysis of patients meeting the inclusion criteria from 2005 to present. Study will also be conducted by the PI, Sub-Is, surgery fellows, office staff and clinical research coordinator who are delegated to do by the PI. Data will be obtained by looking through either investigator's patients or through a national database. Data will be analyzed primarily by the study conductors.
Recruiting
Interested in participating?
Request InfoKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
About this study
It is reported in the literature that the treatment of any pancreatic disease process, whether benign or malignant, continues to be a huge challenge. For example, patients with adenocarcinoma continue to be diagnosed at an advanced stage with medical and surgical options that are improving in terms of outcome measurements but with much more room for improvement. The investigator's goal is to continue to review our treatment outcomes to further improve overall survival, overall symptom control, mortality, and morbidity.
The main aim of this study is to evaluate and compare the outcomes from the investigator's decisions on multiple treatments of benign or malignant pancreatic diseases.There is a need to understand and improve the current diagnosis and treatment algorithm for pancreatic pathologies. Continued evaluation and study is imperative to ensure that national guidelines are improving to enhance patient cure and/or recovery.
All past patients who were treated for a particular benign or malignant pancreatic disease process under evaluation from 2005 to present will be included in this study.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- • All patients diagnosed and treated for pancreatic diseases, benign or malignant from 2005 to present
- Age ≥18 years
Exclusion criteria
- • Patients that are not diagnosed with or treated for pancreatic diseases
- Age < 18 years
Treatment and study plan
Primary outcomes
-
Overall survival
Time frame: 2005 to 2019
Number of patients who have been diagnosed with benign or malignant pancreatic disease
Study contacts
Contact information is provided by the study sponsor or research team.
Crystee Cooper, DHEd
CONTACT
Nitasha Phatak, Ph.D.
CONTACT
Sponsors and collaborators
Lead sponsor
Methodist Health System
Other
Registry information
Important dates
- Study start
- 2019
- Primary completion
- 2027
- Study completion
- 2028
- First posted
- Aug 13, 2019
- Registry last updated
- Jun 10, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.